re: Ann: Transcript of CAN-003 data conferenc... Hi macenroc
1 point to keep in mind about the Edison piece, it was released prior to the announcement of Fast Track status being granted by the FDA. Depending on how much you think that will impact the timeline, the market launch potentially moves up. It also doesn't consider the possibility of Breakthrough Therapy Designation, which would be the real game changer.
P/E for Biotech's.....that's a head scratcher!
At one point DNDN was priced at an absurd 40 times earnings, then came plummeting down when revenue failed to meet expectations, production costs blew out and the massive debt load became apparent.
Personally, I like to work on the basis of a conservative P/E of 10-13 x stabilised earnings, post commercial launch.
- Forums
- ASX - By Stock
- IMM
- Ann: Transcript of CAN-003 data conference call
Ann: Transcript of CAN-003 data conference call , page-16
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
35.5¢ |
Change
0.060(20.3%) |
Mkt cap ! $515.6M |
Open | High | Low | Value | Volume |
36.0¢ | 37.5¢ | 33.5¢ | $6.427M | 18.03M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 35.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
36.0¢ | 133736 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 0.355 |
2 | 9500 | 0.350 |
4 | 199315 | 0.345 |
10 | 84868 | 0.340 |
2 | 10985 | 0.335 |
Price($) | Vol. | No. |
---|---|---|
0.360 | 96182 | 4 |
0.365 | 81517 | 4 |
0.370 | 150545 | 8 |
0.375 | 156434 | 4 |
0.380 | 167642 | 11 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |